Superior to Taxus DES

RESOLUTE Japan: Superior to Taxus DES

*Prespecified superiority analysis if noninferiority test was met.

 

Excellent Safety and Efficacy Outcomes

RESOLUTE Japan: Excellent Safety and Efficacy Outcomes

 

RESOLUTE global clinical program supports Resolute Integrity DES.

 

RESOLUTE Japan

RESOLUTE Japan: Trial Design

 


Challenging Cases with a High Percentage of Diabetic Patients

Baseline patient characteristics

Variable, % N = 100 Patients
Age (yr) 64.1 ±10.7
Male 77.0
Diabetes mellitus 45.0
   IDDM 10.0
Hypertension 81.0
Hyperlipidemia 78.0
Current smoker 22.0
Family history 6.4
Prior MI 25.0
Prior PCI 42.0
Prior CABG 0
Cardiac status
   Stable angina 62.0
   Unstable angina 12.0
   Myocardial infarction 0

 

RESOLUTE global clinical program supports Resolute Integrity DES.

 

Clinical Data Overview

RESOLUTE All Comers
24 Month Results Summary

 
 

Email Page

Send a link to this page by email along with your comments.
Please enter the information below.

  1. (required)
  2. (required)
  3. (required)